Pharmacists play a crucial role in managing headaches in patients on complement inhibitors for PNH, ensuring proper education and risk mitigation strategies.
Mona El-Mouwfi, PharmD Candidate
Advertisement
Articles by Mona El-Mouwfi, PharmD Candidate
Mona El-Mouwfi explores how pharmacists enhance hydroxyurea therapy for sickle cell disease, improving patient outcomes and addressing treatment barriers effectively.
Advertisement
Latest Updated Articles
Changing the Course of SCD: One Dose of Hydroxyurea at a TimePublished: August 4th 2025 | Updated:
Headache or Harm: A Pharmacist’s Role in Differentiating Complement Inhibitor Adverse EffectsPublished: August 7th 2025 | Updated:
Advertisement
Advertisement
Trending on Pharmacy Times
1
Eli Lilly, Novo Nordisk Strike MFN Deals With Trump Administration to Lower GLP-1 Prices
2
Environmental Factors Could Influence Type 1 Diabetes Risk in Children Through Epigenetic Changes
3
Targeting Mitochondrial Metabolism in Heart Failure: From Genetic Drivers to Fuel Modulation Therapies
4
Evolving Mortality Trends in Heart Failure and Vascular Disease: The Critical Role of Pharmacists in Addressing Cardiovascular Risk
5
